Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-21

Clinical Trial Update: Curcumin for the Prevention of Colon Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating curcumin for the prevention of colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED